Das Bergbauunternehmen ist seit Oktober 2020 nicht mehr an einer Börse gelistet. Das Delisting von Lions Bay Mining Corp. fand aufgrund einer Umstrukturierung statt.
Ältere Artikel von und über die Gesellschaft befinden sich im Archiv.
Lions Bay freut sich bekannt zu geben, dass sich die Firma BioVaxys LLC nach eigenen Angaben derzeit auf eine präklinische Studie zu seinem geschützten Impfstoff gegen SARS-CoV-2, den Erreger der Covid-19-Erkrankung, vorbereitet. Wie Lions Bay vor Kurzem mitteilte, hat das Unternehmen eine unverbindliche Absichtserklärung datiert mit 17.4.2020 zur [...]
Lions Bay Mining Corp. kündigte gestern an, dass es eine nicht bindende Absichtserklärung mit BioVaxys LLC geschlossen hat, in deren Rahmen Lions Bay das Unternehmen erwerben wird. Dabei soll BioVaxys unternehmenseigene Tochtergesellschaft von Lions Bay werden. Die Absichtserklärung unterliegt verschiedener Regulierungen und Bedingungen, und zur [...]
BioVaxys Technology is pleased to announce that interim results from its ongoing preclinical animal study of BXV-0320, its SARS-CoV-2 vaccine candidate, show a good emerging tolerability profile with no observed side effects or noteworthy clinical observations. Five weeks post-administration of BVX-0320 in the murine animal model, no toxicities [...]
BioVaxys Technology Corp. is pleased to announce the completion of its formerly announced acquisition of all of the securities BioVaxys Inc. The Transaction was determined to be a "fundamental change" pursuant to the policies of the Canadian Securities Exchange and the Company has re-classified itself from being a resource issuer to an industrial [...]
Lions Bay Mining is pleased to announce that it has closed the second and final tranche of its previously announced non-brokered private placement. Under the final tranche of the Private Placement, the Company issued 2,954,582 units at a price of $0.22 per Unit for total gross proceeds of approximately $650,008.00, and together with the first [...]
Lions Bay Mining Corp. is pleased to announce that, following the execution of a Share Exchange Agreement with BioVaxys, the Company has executed a USD$180,000 secured lending facility with BioVaxys, the proceeds of which will be used primarily for BioVaxys' preclinical studies of BVX-0320, a novel vaccine candidate for prevention of Covid-19 [...]
Lions Bay Mining is pleased to announce that it has executed a Share Exchange Agreement with BioVaxys Inc., a clinical-stage immunotherapeutics company developing vaccine platforms for SARS-CoV-2 and various cancers. Under the terms of transaction, the Company will acquire all of the issued and outstanding shares of common stock of BioVaxys. Terms [...]
